Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Cancer Therapeutics Laboratories Inc
Profile last edited on: 2/17/2014      CAGE: 45VX6      UEI: KS2BU4J2PHE3

Business Identifier: Cancer treating therapies
Year Founded
1994
First Award
2004
Latest Award
2010
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2011 Zonal Avenue Hmr 205
Los Angeles, CA 90089
   (323) 442-1172
   aepstein@usc.edu
   N/A
Location: Single
Congr. District: 37
County: Los Angeles

Public Profile

Cancer Therapeutics Laboratories is a California-based corporation owned by doctors for the research and development of cancer treating therapies. CTL performs research regarding an antibody technology called Tumor Necrosis Therapy (TNT), which is a method by which cancer cells can be located and killed

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$619,455
Phase II Dollars
$320,000
Total Awarded
$939,455

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2010 1 NIH $299,456
Project Title: Tas::75 0849::Tas The Main Technical Objective Of This Contract Is To Generate
2005 2 NIH $639,999
Project Title: Monoclonal Antibodies Against T-Regulatory Cells

Key People / Management

  Alan L Epstein -- President

  Hu Peisheng

Company News

There are no news available.